Mar 26 |
Mirum Pharmaceuticals Inc (MIRM) Insider Sells Shares
|
Mar 25 |
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
|
Mar 15 |
Mirum's (MIRM) Livmarli Receives FDA Nod for Expanded Use
|
Mar 14 |
Mirum gains as FDA accepts label expansion of liver disease drug
|
Mar 13 |
Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
|
Mar 5 |
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
|
Mar 5 |
Mirum Pharmaceuticals: Advancing On Several Key Fronts
|
Feb 29 |
Critical Insights From Mirum Pharmaceuticals Analyst Ratings: What You Need To Know
|
Feb 29 |
Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
|
Feb 29 |
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q4 2023 Earnings Call Transcript
|